Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.Solid TumorRecruitingPhase 1 / Phase 22025-06-03NCT06603844

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Corbus Pharmaceuticals Inc.3

26 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Advent Health Oncology HematologyOrlandoUnited States1
Beatson West of Scotland Cancer CenterGlasgowUnited Kingdom2
Cedars-Sinai Medical CenterLos AngelesUnited States1
Duke Cancer CenterDurhamUnited States44
Edinburgh Cancer Research CentreEdinburghUnited Kingdom1
Guys and St Thomas NHS Foundation TrustLondonUnited Kingdom13
Nebraska Hematology OncologyLincolnUnited States2
SCRI - Arizona Oncology AssociatesTucsonUnited States1
SCRI - Minnesota Oncology HematologyMaple GroveUnited States1
SCRI - NashvilleNashvilleUnited States1
SCRI - Oncology and Hematology Associates of Southwest VirginiaRoanokeUnited States1
SCRI - OU Health Stephenson Cancer CenterOklahoma CityUnited States1
SCRI - Rocky Mountain Cancer CentersDenverUnited States1
SCRI - Virginia Cancer SpecialistsFairfaxUnited States1
SCRI- Lake Nona DDUOrlandoUnited States1
SCRI- Texas OncologyTylerUnited States1
START - San AntonioSan AntonioUnited States7
The Christie NHS Foundation Trust - Christie HospitalManchesterUnited Kingdom1
The Clatterbridge Cancer Center NHS Foundation TrustBirkenheadUnited Kingdom1
The Newcastle upon Tyne Hospitals NHS Foundation TrustNewcastle upon TyneUnited Kingdom1
The University of Arizona Cancer CenterTucsonUnited States14
UC San Diego Health - Moores Cancer CenterLa JollaUnited States2
University Hospital of Cleveland (Case Western)ClevelandUnited States1
University of Alabama at BirminghamBirminghamUnited States247
University of California San FranciscoSan FranciscoUnited States144